Estudo experimental da inibição da proliferação vitreorretiniana pelo uso da hiperecina

作者: Roberto Augusto Fernandes Machado , Antonio Marcelo Barbante Casella , Marcus Rudolph Malaguido , Ana Paula Miyagusko Taba Oguido

DOI: 10.1590/S0004-27492009000500010

关键词: PlaceboSurgeryDiathermyHypericinRetinographyProliferative vitreoretinopathySalineRetinalOphthalmologyDispaseMedicine

摘要: PURPOSE: To produce proliferative vitreoretinopathy (PVR) in an animal ocular trauma model. evaluate the inhibition of emergence and progression by hypericin. METHODS: Experimental Study. Nineteen pigmented male adult rabbits weighing between 2,000 3,000 grams were used this study. All them submitted to model with dispase retinal diathermy induce PVR membranes formation. They randomly assigned receive hypericin (10 µM 0.1 ml) or saline solution (0.1 as placebo. evaluated clinically seventh, fourteenth, twenty-first twenty-eighth postoperative days indirect ophthalmoscopy digital color retinography. The degree was classified according Hida (0 7). RESULTS: Membranes formation present 79% eyes; being 100% eyes placebo group 60% treatment (hypericin). comparison phases averages within groups showed a statistically significant difference two groups, p value 0.0321 for Wilcoxon test. CONCLUSIONS: produces vitreoretinal membranes. Hypericin considered effective decrease.

参考文章(27)
D S Gregerson, J D Cameron, A W Walsh, E M Frenzel, K A Neely, A New Model of Proliferative Vitreoretinopathy Investigative Ophthalmology & Visual Science. ,vol. 39, pp. 2157- 2164 ,(1998)
Qianying Gao, Yusheng Wang, Yannian Hui, Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits Yan ke xue bao = Eye science / "Yan ke xue bao" bian ji bu. ,vol. 18, pp. 240- 245 ,(2002)
Riaz Hassan Yusuf Asaria, Chee Hing Kon, Catey Bunce, David G Charteris, David Wong, Peng Tee Khaw, George William Aylward, Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial Ophthalmology. ,vol. 108, pp. 1179- 1183 ,(2001) , 10.1016/S0161-6420(01)00589-9
Shwu-Jiuan Sheu, Taiji Sakamoto, Roman Osusky, Hsin-Min Wang, Thomas E. Ogden, Stephen J. Ryan, David R. Hinton, Rayudu Gopalakrishna, Transforming growth factor-β regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 232, pp. 695- 701 ,(1994) , 10.1007/BF00171387
Walter H. Stern, Geoffrey P. Lewis, Christopher J. Guerin, James J. O'Donnell, Page A. Erickson, Don H. Anderson, Steven K. Fisher, Fluorouracil Therapy for Proliferative Vitreoretinopathy after Vitrectomy American Journal of Ophthalmology. ,vol. 96, pp. 33- 42 ,(1983) , 10.1016/0002-9394(83)90452-X
Mark S. Blumenkranz, Avinoam Ophir, Alice J. Claflin, Anthony Hajek, Fluorouracil for the Treatment of Massive Periretinal Proliferation American Journal of Ophthalmology. ,vol. 94, pp. 458- 467 ,(1982) , 10.1016/0002-9394(82)90239-2
Ugur Ozerdem, Beata Mach-Hofacre, Kelly Keefe, Tony Pham, Kelly Soules, Krzysztof Appelt, William R. Freeman, The Effect of Prinomastat (AG3340), a Synthetic Inhibitor of Matrix Metalloproteinases, on Posttraumatic Proliferative Vitreoretinopathy Ophthalmic Research. ,vol. 33, pp. 20- 23 ,(2001) , 10.1159/000055636
T. Hida, D. B. Chandler, S. M. Sheta, Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 225, pp. 303- 307 ,(1987) , 10.1007/BF02150154
PHILIPPE GIRARD, GÉRARD MIMOUN, IOANIS KARPOUZAS, GUY MONTEFIORE, CLINICAL RISK FACTORS FOR PROLIFERATIVE VITREORETINOPATHY AFTER RETINAL DETACHMENT SURGERY Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 14, pp. 417- 424 ,(1994) , 10.1097/00006982-199414050-00005